Akoya Biosciences Announces a Groundbreaking Collaboration with PathAI to Combine Spatial Biology with AI-Powered Tools to Facilitate Discovery of Novel Predictive Biomarkers
13 déc. 2021 08h05 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, and PathAI, a global leader in artificial intelligence (AI)-powered...
Curesponse Secures Additional USD 8 Million Funding for Its Breakthrough Precision Oncology Platform
15 nov. 2021 14h35 HE
|
Curesponse
REẖOVOT, Israel, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Curesponse (www.curesponse.com) has secured additional USD 8 million funding for its breakthrough precision oncology platform. Curesponse is a...
Global Market for Immuno-Oncology Diagnostics 2021: Diagnostics Play New Key Role in Therapeutic Development and Clinical Trials
01 nov. 2021 05h48 HE
|
Research and Markets
Dublin, Nov. 01, 2021 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates, 2022 - 2026" report has been added to ResearchAndMarkets.com's...
Akoya Biosciences Appoints Diagnostics Industry Pioneer Myla Lai-Goldman, MD, to its Board of Directors
22 sept. 2021 08h05 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (NASDAQ: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the appointment of Myla Lai-Goldman, MD, a true...
PD-1 Resistant Head and Neck Cancer (HNC) Market Landscape Report 2021
31 août 2021 04h08 HE
|
Research and Markets
Dublin, Aug. 31, 2021 (GLOBE NEWSWIRE) -- The "PD-1 Resistant Head and Neck Cancer (HNC) - Market Insight, Epidemiology and Market Forecast 2030" report has been added to ResearchAndMarkets.com's...
TCR-based Therapies Market Research Report 2021
16 juil. 2021 04h58 HE
|
Research and Markets
Dublin, July 16, 2021 (GLOBE NEWSWIRE) -- The "TCR-based Therapies Market by Target Indications, Target Antigens, Key Players and Key Geographies, Industry Trends and Global Forecasts, 2021-2030"...
Outlook on the Oncolytic Virus Immunotherapy Global Market to 2026 - Key Drivers and Inhibitors
20 oct. 2020 04h08 HE
|
Research and Markets
Dublin, Oct. 20, 2020 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Immunotherapy Market, Dosage, Price & Clinical Trials Outlook 2026" report has been added to ResearchAndMarkets.com's...
Global Immuno-Oncology Diagnostics Markets 2020-2024: Focus on Biomarkers and the Next Five Years
01 oct. 2020 07h29 HE
|
Research and Markets
Dublin, Oct. 01, 2020 (GLOBE NEWSWIRE) -- The "The Race for Biomarkers Market Forecasts for Immuno-Oncology Diagnostics, With Exutive and Consultant Guides and including Customized Forecasting and...
OTraces’ TME Cancer Blood Test Presentation at Innovation Challenge Spurs Investor Interest from JP Morgan Healthcare Conference Participants
11 janv. 2018 13h39 HE
|
OTraces, Inc.
SAN FRANCISCO and BALTIMORE, Jan. 11, 2018 (GLOBE NEWSWIRE) -- OTraces Inc., a Sykesville, Maryland-based cancer diagnostics company with a unique patented and patent-pending blood test which...
Biothera Announces Three Presentations at Upcoming American Association for Cancer Research (AACR) Annual Meeting
27 mars 2017 11h00 HE
|
Biothera Pharmaceuticals, Inc.
EAGAN, Minn., March 27, 2017 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals Inc. announced today that it will present three scientific posters at the American Association for Cancer Research (AACR)...